Company · RAPP · CIK 2012593

Rapport Therapeutics, Inc. (RAPP) SEC filings and CIK.

RAPP’s SEC Central Index Key (CIK) is 0002012593, or 2012593 without leading zeros. The SEC’s ticker file lists it as Rapport Therapeutics, Inc..

Ticker
RAPP
CIK
0002012593
Other tickers
None
Insider transactions, Q3 2026
25

Insider trading

In Q3 2026, insiders at Rapport Therapeutics, Inc. reported 25 non-derivative transactions on 10 Forms 3, 4 and 5, including 0 open-market purchases and 25 sales. See every RAPP insider transaction →

Recent filings we observed

From our record of EDGAR’s latest-filings feed and sampled daily indexes. Not a complete filing history; use the filings API for that.
FiledFormAccession
2026-10-308-K0001193125-26-441851
2026-10-3040001104659-26-120789
2026-10-30424B50001193125-26-439869
2026-10-30424B50001193125-26-439863

Get RAPP SEC data through the API

Filing history
curl "https://sec-api.dev/api/v1/filings?cik=2012593&limit=10" \
  -H "Authorization: Bearer $SEC_API_KEY"
Company profile
curl "https://sec-api.dev/api/v1/companies/2012593" \
  -H "Authorization: Bearer $SEC_API_KEY"
Reported XBRL facts
curl "https://sec-api.dev/api/v1/facts/2012593?taxonomy=us-gaap&concept=Revenues&limit=10" \
  -H "Authorization: Bearer $SEC_API_KEY"

Ticker to CIK API · SEC filings API · Rapport Therapeutics, Inc. on SEC.gov

Questions

What is RAPP’s CIK number?

RAPP’s SEC Central Index Key (CIK) is 0002012593, or 2012593 without leading zeros. The SEC’s ticker file lists it as Rapport Therapeutics, Inc..

How do I find Rapport Therapeutics, Inc.’s 10-K?

Request /api/v1/filings?cik=2012593&form=10-K, or open the company’s EDGAR page and filter by 10-K. Foreign issuers file 20-F or 40-F instead.

Ticker and CIK: SEC company_tickers.json, cached 2026-11-02. Tickers can move between entities; the CIK identifies the filer.

Plain-text version for agents and LLMs: /companies/rapp.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.